October 27, 2025
When a nationwide blood-culture bottle shortage squeezed hospitals, a Stanford-led team turned to machine learning by building and openly sharing tools that predict which patients are most likely to have bacteremia and when a culture can be safely deferred. The simplest version works as a quick bedside score, no new software required.
October 27, 2025
A Bangladesh research team unveiled a suitcase-sized, point-of-care test that detects Nipah virus from respiratory patients in about 30 minutes, showing accuracy comparable to RT-PCR, and designed to bring rapid diagnosis and outbreak control to rural, low-resource settings.
October 27, 2025
From hand-hygiene audits to the SHEA Board of Trustees, the professional path of Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, traces the arc of modern infection prevention. The former hospital IP—now a University of Pittsburgh assistant professor—pairs frontline experience with genomic epidemiology to turn sequencing into outbreak-stopping action.
October 27, 2025
When Hurricane Helene flooded a North Carolina facility and sparked an IV fluid shortage, Duke’s stewardship network turned crisis into practice change—rapidly shifting eligible patients to highly bioavailable oral antibiotics and boosting PO use by 5.6% across participating hospitals.
October 23, 2025
At IDWeek in Atlanta, former CDC director Tom Frieden unveiled a crisp playbook for infection prevention—“See. Believe. Create.”—arguing it can help hospitals spot outbreaks sooner, reverse drug resistance, and drive HAIs toward zero. He paired the message with a 7-1-7 target: 7 days to find an outbreak, 1 to report, 7 to control.
December 17, 2024
IDWeek 2024 continues to give encouraging studies. Check out several more from CSL Seqirus and Shionogi.
November 20, 2024
Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
November 19, 2024
Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
October 23, 2024
Peter Rabinowitz, MD, MPH, discusses how climate change, including extreme weather and temperature shifts, is reshaping the spread of infectious diseases like dengue, leptospirosis, and Valley fever.
October 18, 2024
The rise of multidrug-resistant gonorrhea highlights the urgent need for new therapies. Zoliflodacin, a promising oral antibiotic, shows effectiveness in late-stage trials.